Literature DB >> 34266581

Pathophysiology of the Lymphatic System in Patients With Heart Failure: JACC State-of-the-Art Review.

Maxim Itkin1, Stanley G Rockson2, Daniel Burkhoff3.   

Abstract

The removal of interstitial fluid from the tissues is performed exclusively by the lymphatic system. Tissue edema in congestive heart failure occurs only when the lymphatic system fails or is overrun by fluid leaving the vascular space across the wall of the capillaries into the interstitial space. This process is driven by Starling forces determined by hydrostatic and osmotic pressures and organ-specific capillary permeabilities to proteins of different sizes. In this review, we summarize current knowledge of the generation of lymph in different organs, the mechanics by which lymph is returned to the circulation, and the consequences of the inadequacy of lymph flow. We review recent advances in imaging techniques that have allowed for new research, diagnostic, and therapeutic approaches to the lymphatic system. Finally, we review how efforts to increase lymph flow have demonstrated potential as a viable therapeutic approach for refractory heart failure.
Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MR lymphangiography; Starling equation; heart failure; lymphatic system

Mesh:

Year:  2021        PMID: 34266581     DOI: 10.1016/j.jacc.2021.05.021

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

Review 1.  Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.

Authors:  Jessica H Huston; Sanjiv J Shah
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

Review 2.  The Effects of Exercise-Based Interventions on Fluid Overload Symptoms in Patients with Heart Failure: A Systematic Review and Meta-Analysis.

Authors:  Mei Rosemary Fu; Yuan Li; Catherine Conway; Alessandra Masone; Jinbo Fang; Christopher Lee
Journal:  Biomedicines       Date:  2022-05-11

3.  Exploring disease interrelationships in patients with lymphatic disorders: A single center retrospective experience.

Authors:  Stanley G Rockson; Xin Zhou; Lan Zhao; Davood K Hosseini; Xinguo Jiang; Andrew J Sweatt; Dongeon Kim; Wen Tian; Michael P Snyder; Mark R Nicolls
Journal:  Clin Transl Med       Date:  2022-04

Review 4.  Lymphatic Clearance of Immune Cells in Cardiovascular Disease.

Authors:  Christophe Ravaud; Nikita Ved; David G Jackson; Joaquim Miguel Vieira; Paul R Riley
Journal:  Cells       Date:  2021-09-29       Impact factor: 7.666

Review 5.  Targeting the vasculature in cardiometabolic disease.

Authors:  Nabil E Boutagy; Abhishek K Singh; William C Sessa
Journal:  J Clin Invest       Date:  2022-03-15       Impact factor: 14.808

Review 6.  Suppression of Cardiogenic Edema with Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction: Mechanisms and Insights from Pre-Clinical Studies.

Authors:  Ryan D Sullivan; Mariana E McCune; Michelle Hernandez; Guy L Reed; Inna P Gladysheva
Journal:  Biomedicines       Date:  2022-08-19

Review 7.  The interstitial compartment as a therapeutic target in heart failure.

Authors:  Doron Aronson
Journal:  Front Cardiovasc Med       Date:  2022-08-17

Review 8.  Device-based therapy for decompensated heart failure: An updated review of devices in development based on the DRI2P2S classification.

Authors:  Cristiano de Oliveira Cardoso; Abdelmotagaly Elgalad; Ke Li; Emerson C Perin
Journal:  Front Cardiovasc Med       Date:  2022-09-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.